SOTERA HEALTH COMPANY Amortization of Debt Issuance Costs
SOTERA HEALTH COMPANY (SHC) reported Amortization of Debt Issuance Costs of $3.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-06
- SOTERA HEALTH COMPANY amortization of debt issuance costs for the quarter ending 2026-06-30 was $1.63M, a 18.33% increase year-over-year.
- SOTERA HEALTH COMPANY amortization of debt issuance costs for the quarter ending 2026-03-31 was $1.47M, a 15.51% increase year-over-year.
- SOTERA HEALTH COMPANY amortization of debt issuance costs for the quarter ending 2025-12-31 was $1.48M, a 15.94% increase year-over-year.
- SOTERA HEALTH COMPANY amortization of debt issuance costs for the quarter ending 2025-09-30 was $1.30M, a 4.07% increase year-over-year.
- SOTERA HEALTH COMPANY amortization of debt issuance costs for fiscal 2025 was $5.43M, a 24.92% decline from fiscal 2024.
- SOTERA HEALTH COMPANY amortization of debt issuance costs for fiscal 2024 was $7.24M, a 20.03% decline from fiscal 2023.
- SOTERA HEALTH COMPANY amortization of debt issuance costs for fiscal 2023 was $9.05M, a 59.32% increase from fiscal 2022.
- SOTERA HEALTH COMPANY amortization of debt issuance costs for fiscal 2022 was $5.68M, a 7.79% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.09M 10-Q · filed 2026-08-06 | $4.58M derived: sum of 3 quarters · filed 2026-08-06 | $5.88M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.47M 10-Q · filed 2026-05-05 | $2.95M derived: sum of 2 quarters · filed 2026-05-05 | $4.26M derived: sum of 3 quarters · filed 2026-05-05 | $5.63M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.79M derived: sum of 2 quarters · filed 2026-02-24 | $4.16M derived: sum of 3 quarters · filed 2026-08-06 | $5.43M 10-K · filed 2026-02-24 |
| 2025-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.68M derived: sum of 2 quarters · filed 2026-08-06 | $3.95M 10-Q · filed 2025-11-04 | $5.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.65M 10-Q · filed 2026-08-06 | $3.92M derived: sum of 3 quarters · filed 2026-08-06 | $5.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.27M 10-Q · filed 2026-05-05 | $2.55M derived: sum of 2 quarters · filed 2026-05-05 | $3.80M derived: sum of 3 quarters · filed 2026-05-05 | $5.97M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $2.53M derived: sum of 2 quarters · filed 2026-02-24 | $4.70M derived: sum of 3 quarters · filed 2026-02-24 | $7.24M 10-K · filed 2026-02-24 |
| 2024-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.42M derived: sum of 2 quarters · filed 2025-11-04 | $5.96M 10-Q · filed 2025-11-04 | $8.49M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $4.70M 10-Q · filed 2025-08-08 | $7.23M derived: sum of 3 quarters · filed 2026-02-24 | $9.64M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $2.54M 10-Q · filed 2025-05-01 | $5.06M derived: sum of 2 quarters · filed 2026-02-24 | $7.47M derived: sum of 3 quarters · filed 2026-02-24 | $9.68M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.94M derived: sum of 2 quarters · filed 2026-02-24 | $7.14M derived: sum of 3 quarters · filed 2026-02-24 | $9.05M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $4.61M derived: sum of 2 quarters · filed 2024-11-05 | $6.52M 10-Q · filed 2024-11-05 | $7.94M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $4.11M 10-Q · filed 2024-08-05 | $5.53M derived: sum of 3 quarters · filed 2025-02-27 | $6.96M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $1.91M 10-Q · filed 2024-05-02 | $3.33M derived: sum of 2 quarters · filed 2025-02-27 | $4.75M derived: sum of 3 quarters · filed 2025-02-27 | $6.18M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.85M derived: sum of 2 quarters · filed 2025-02-27 | $4.27M derived: sum of 3 quarters · filed 2025-02-27 | $5.68M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $2.85M derived: sum of 2 quarters · filed 2023-11-01 | $4.26M 10-Q · filed 2023-11-01 | $5.63M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.84M 10-Q · filed 2023-08-03 | $4.21M derived: sum of 3 quarters · filed 2024-02-27 | $5.75M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.41M 10-Q · filed 2023-05-03 | $2.79M derived: sum of 2 quarters · filed 2024-02-27 | $4.33M derived: sum of 3 quarters · filed 2024-02-27 | $5.91M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $2.92M derived: sum of 2 quarters · filed 2024-02-27 | $4.50M derived: sum of 3 quarters · filed 2024-02-27 | $6.16M 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $3.13M derived: sum of 2 quarters · filed 2022-11-02 | $4.79M 10-Q · filed 2022-11-02 | $7.58M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $3.25M 10-Q · filed 2022-08-04 | $6.04M derived: sum of 3 quarters · filed 2023-02-28 | $9.04M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $1.66M 10-Q · filed 2022-05-05 | $4.46M derived: sum of 2 quarters · filed 2023-02-28 | $7.46M derived: sum of 3 quarters · filed 2023-02-28 | $10.31M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.79M derived: sum of 2 quarters · filed 2023-02-28 | $8.65M derived: sum of 3 quarters · filed 2023-02-28 | $11.62M 10-K · filed 2023-02-28 |
| 2020-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $5.85M derived: sum of 2 quarters · filed 2021-11-10 | $8.83M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.83M 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $2.98M 10-Q · filed 2021-05-13 | |||
| 2019-12-31 | $8.29M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |